News
Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...
During the three-day visit, the Swiss delegation will highlight Switzerland’s substantial investments in the United States, ...
Investing.com - European equity indices mainly slipped lower Thursday as the relief rally stalled, with investors digesting a ...
Investing.com -- Roche on Thursday reported a 6% increase in group sales for the first quarter of 2025, driven by strong ...
FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by ...
The Swiss National Bank said on Thursday it posted a first quarter profit of 6.7 billion Swiss francs ($8.08 billion), as ...
Swiss drugmaker Roche said on Thursday its first-quarter sales rose 7% to 15.44 billion Swiss francs ($18.64 billion) and it ...
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the pharmaceutical company has their eyes on Indiana. Roche, a Swiss company, ...
Latin Times on MSN11h
$50B U.S. Push Swiss Pharma Leader Roche Fights Tariff ThreatsRoche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...
Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results